January 20, 2025 Maria Dranishnikova Goldman Sachs raises target price for dermatological drug maker MoonLake by 32%
January 16, 2025 Maria Dranishnikova Royce Small-Cap Total Return Fund reveals biggest contributing and detracting holdings
January 14, 2025 Maria Dranishnikova AI beauty solutions developer Perfect Corp. sees target price upgraded after acquisition of competitor
January 6, 2025 Maria Dranishnikova The Motley Fool highlights three stocks that could double returns for investors
January 3, 2025 Maria Dranishnikova Freedom Broker highlights three small-cap companies with high growth potential in 2025
December 20, 2024 Maria Dranishnikova Wedbush expects ‘under-the-radar AI name’ Innodata to surge 40% in 2025
December 19, 2024 Maria Dranishnikova Freedom Broker spotlights three small caps ahead of Santa Claus rally
December 16, 2024 Maria Dranishnikova Royce looks at three innovators in the payments processing industry
December 13, 2024 Maria Dranishnikova Barchart.com highlights two Wall Street ‘strong buys’ from the Russell 2000
December 12, 2024 Maria Dranishnikova Piper Sandler sees the Russell 2000 outperforming the S&P 500 in 2025
December 11, 2024 Maria Dranishnikova Zacks sees 222% upside in weight-loss market innovator Lexaria Bioscience
December 10, 2024 Maria Dranishnikova Barron’s spotlights six S&P 600 stocks set to keep rallying in 2025
December 6, 2024 Maria Dranishnikova WSJ notes biggest gainers in the small-cap S&P 600 since Trump victory
December 4, 2024 Maria Dranishnikova Zacks SCR reiterates 400% upside call on Nurexone Biologic for risk-tolerant investors
November 29, 2024 Maria Dranishnikova Zacks sees 400% upside for MediciNova amid incoming damages from Sanofi/Novartis dispute
November 28, 2024 Maria Dranishnikova Stock Trader’s Almanac sees jollier than usual Santa Claus rally for small caps